Literature DB >> 23908028

Preliminary crystallographic analysis of neuraminidase N2 from a new influenza A virus.

Feng Gao1, Jinku Bao.   

Abstract

Influenza virus is a major viral respiratory pathogen that causes yearly epidemics in temperate climates. The H3N2 subtype is one of the major causative agents of severe epidemics and plays a critical role in vaccine development. The neuraminidase (NA) inhibitors oseltamivir and zanamivir are two commercially available NA-targeted competitive antiviral drugs. However, their effectiveness has been compromised by the rapid emergence of resistance. Q136K is a novel mutation in NA which confers resistance to zanamivir. In this study, a Q136K mutant N2 protein was expressed in a baculovirus system and crystals were obtained. The crystal of N2 belonged to space group P2₁2₁2₁, with unit-cell parameters a = 109.5, b = 112.8, c = 165.2 Å. Data were collected to 2.4 Å resolution. Four monomers were found in the asymmetric unit. The Matthews coefficient and solvent content were calculated to be 3.0 ų Da⁻¹ and 59.0%, respectively.

Entities:  

Keywords:  drug resistance; influenza A virus; neuraminidases

Mesh:

Substances:

Year:  2013        PMID: 23908028      PMCID: PMC3729159          DOI: 10.1107/S1744309113013122

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  17 in total

1.  Molecular replacement with MOLREP.

Authors:  Alexei Vagin; Alexei Teplyakov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

2.  Antigenic variation of H1N1, H1N2 and H3N2 swine influenza viruses in Japan and Vietnam.

Authors:  Nobuhiro Takemae; Tung Nguyen; Long Thanh Ngo; Yasuaki Hiromoto; Yuko Uchida; Vu Phong Pham; Tsutomu Kageyama; Shizuko Kasuo; Shinichi Shimada; Yasutaka Yamashita; Kaoru Goto; Hideyuki Kubo; Vu Tri Le; Hung Van Vo; Hoa Thi Do; Dang Hoang Nguyen; Tsuyoshi Hayashi; Aya Matsuu; Takehiko Saito
Journal:  Arch Virol       Date:  2013-02-23       Impact factor: 2.574

3.  The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site.

Authors:  Qing Li; Jianxun Qi; Wei Zhang; Christopher J Vavricka; Yi Shi; Jinhua Wei; Enguang Feng; Jingshan Shen; Jilong Chen; Di Liu; Jianhua He; Jinghua Yan; Hong Liu; Hualiang Jiang; Maikun Teng; Xuebing Li; George F Gao
Journal:  Nat Struct Mol Biol       Date:  2010-09-19       Impact factor: 15.369

4.  Avian flu: isolation of drug-resistant H5N1 virus.

Authors:  Q Mai Le; Maki Kiso; Kazuhiko Someya; Yuko T Sakai; T Hien Nguyen; Khan H L Nguyen; N Dinh Pham; Ha H Ngyen; Shinya Yamada; Yukiko Muramoto; Taisuke Horimoto; Ayato Takada; Hideo Goto; Takashi Suzuki; Yasuo Suzuki; Yoshihiro Kawaoka
Journal:  Nature       Date:  2005-10-20       Impact factor: 49.962

5.  Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution.

Authors:  J N Varghese; P M Colman
Journal:  J Mol Biol       Date:  1991-09-20       Impact factor: 5.469

6.  Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.

Authors:  Aeron C Hurt; Jessica K Holien; Michael Parker; Anne Kelso; Ian G Barr
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

7.  Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.

Authors:  P Bossart-Whitaker; M Carson; Y S Babu; C D Smith; W G Laver; G M Air
Journal:  J Mol Biol       Date:  1993-08-20       Impact factor: 5.469

8.  The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

Authors:  Rupert J Russell; Lesley F Haire; David J Stevens; Patrick J Collins; Yi Pu Lin; G Michael Blackburn; Alan J Hay; Steven J Gamblin; John J Skehel
Journal:  Nature       Date:  2006-08-16       Impact factor: 49.962

9.  Oseltamivir-resistant pandemic (H1N1) 2009 virus, Mexico.

Authors:  José Ernesto Ramirez-Gonzalez; Elizabeth Gonzalez-Duran; Patricia Alcantara-Perez; Claudia Wong-Arambula; Hiram Olivera-Diaz; Iliana Cortez-Ortiz; Gisela Barrera-Badillo; Ha Nguyen; Larisa Gubareva; Irma Lopez-Martinez; Jose Alberto Díaz-Quiñonez; Miguel Angel Lezana-Fernández; Hugo Lopez Gatell-Ramírez; Jose Angel Cordova Villalobos; Mauricio Hernández-Avila; Celia Alpuche-Aranda
Journal:  Emerg Infect Dis       Date:  2011-02       Impact factor: 6.883

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.